Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Chubb
Teva
US Department of Justice
Baxter
Chinese Patent Office
Dow
Colorcon

Generated: May 22, 2018

DrugPatentWatch Database Preview

CEFOBID IN PLASTIC CONTAINER Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Cefobid In Plastic Container patents expire, and when can generic versions of Cefobid In Plastic Container launch?

Cefobid In Plastic Container is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in CEFOBID IN PLASTIC CONTAINER is cefoperazone sodium. There are four drug master file entries for this compound. Additional details are available on the cefoperazone sodium profile page.
Summary for CEFOBID IN PLASTIC CONTAINER
Drug patent expirations by year for CEFOBID IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for CEFOBID IN PLASTIC CONTAINER
Synonyms for CEFOBID IN PLASTIC CONTAINER
(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
[6R-[6alpha,7beta(R*)]]-7-[[[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt
1094606-34-4
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6alpha,7bet
5FQG9774WD
62893-19-0 (Parent)
62893-20-3
AB1009354
AKOS015951266
AN-39116
C08112
C25H26N9NaO8S2
C25H26N9O8S2.Na
CAS-62893-20-3
Cefobid
cefobid sodium salt
Cefobis
Cefoper
Cefoperazin
cefoperazon-natrium
Cefoperazone (sodium salt)
CEFOPERAZONE SODIUM
Cefoperazone sodium (JP17/USP)
Cefoperazone sodium [USAN:JAN]
Cefoperazone sodium [USAN:USP:JAN]
Cefoperazone sodium salt
cefoperazone, sodium salt
CHEBI:3494
CHEMBL1200482
CP 52640-2
CP-52,640-2
CP-52640-2
CP-526402
CS-5023
CTK8F8528
D00918
DSSTox_CID_25874
DSSTox_GSID_45874
DSSTox_RID_81192
DTXSID6045874
EBD47236
EINECS 263-751-5
FT-0603038
HE369092
HY-B0210A
J10387
LS-150057
MFCD07793331
MolPort-003-845-688
NCFTXMQPRQZFMZ-WERGMSTESA-M
NCGC00094952-01
NCGC00179599-03
SCHEMBL537680
Sodium (6R,7R)-7-((R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
sodium (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sodium cefoperazone
sodium;(6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxy
T 1551
T-1551
Tomabef
Tox21_111367
Tox21_111367_1
UNII-5FQG9774WD

US Patents and Regulatory Information for CEFOBID IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CEFOBID IN PLASTIC CONTAINER cefoperazone sodium INJECTABLE;INJECTION 050613-002 Jul 31, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer CEFOBID IN PLASTIC CONTAINER cefoperazone sodium INJECTABLE;INJECTION 050613-001 Jul 23, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Accenture
Harvard Business School
Julphar
Queensland Health
UBS
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.